Saturday, August 12, 2017
From Education Week:
Since being confirmed as U.S. secretary of education in February, Betsy DeVos has significantly increased her family’s financial stake in a company that makes questionable claims about its treatment for conditions such as anxiety, autism, depression, and attention-deficit hyperactivity disorder.
The new investments in the Grand Rapids, Mich.-based Neurocore could total as much as $5.5 million. The investments were reported on two separate financial disclosure forms that DeVos filed with the U.S. Office of Government Ethics in April and June. That office certified both forms. The transactions could reflect purchases made either by DeVos herself or by an immediate family member.
The moves raise new ethical questions for the education secretary and prompt fresh worries from some researchers about DeVos’s commitment to rigorous scientific research.
Neurocore purports to treat patients by analyzing their brainwaves and other biological signs, then providing “neurofeedback sessions” through which they can train their brains to function better. The company often uses such treatments with both adults and children. It charges as much as $2,200 for a 30-session cycle.
You can read more here. One wonders what this enthusiasm for a pop psychology (IMHO) company suggests for future actions of the Department of Education.